Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering.
暂无分享,去创建一个
[1] J. Roth,et al. A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] M. Vallet‐Regí,et al. Biocompatibility and in vivo gentamicin release from bioactive sol-gel glass implants. , 2002, Journal of biomedical materials research.
[3] M. Vallet‐Regí,et al. A New Property of MCM-41: Drug Delivery System , 2001 .
[4] M. Vallet‐Regí,et al. Encapsulation of Ibuprofen in Mesoporous Silica: Solid State NMR Characterization , 2003 .
[5] Thomas,et al. Design, Synthesis, and In Situ Characterization of New Solid Catalysts. , 1999, Angewandte Chemie.
[6] M. Vallet‐Regí,et al. Phosphorous-doped MCM-41 as bioactive material , 2005 .
[7] M. Vallet‐Regí,et al. Release evaluation of drugs from ordered three-dimensional silica structures. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] Jian Liu,et al. Structural relation properties of hydrothermally stable functionalized mesoporous organosilicas and catalysis. , 2005, The journal of physical chemistry. B.
[9] J. Rosenholm,et al. Drug release from biodegradable silica fibers , 2002 .
[10] María Vallet-Regí,et al. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern , 2006 .
[11] M. Vallet‐Regí,et al. Solid State NMR Characterisation of Encapsulated Molecules in Mesoporous Silica , 2004 .
[12] Fredrickson,et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores , 1998, Science.
[13] Victor S-Y Lin,et al. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. , 2005, Angewandte Chemie.
[14] J. Salonen,et al. Use of thermoanalytical methods in quantification of drug load in mesoporous silicon microparticles , 2005 .
[15] J. Devoisselle,et al. Preparation and characterization of siliceous material using liposomes as template. , 2003, Chemical communications.
[16] F. Palumbo,et al. Drug Delivery Devices Based on Mesoporous Silicate , 2004, Drug delivery.
[17] M. Vallet‐Regí,et al. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[18] Yuhan Sun,et al. Famotidine drug adsorption on carboxylic acid functionalized ordered SBA-15 mesoporous silica , 2005 .
[19] M. Vallet‐Regí,et al. MCM-41 Organic Modification as Drug Delivery Rate Regulator , 2003 .
[20] Chung-Yuan Mou,et al. Well-Ordered Mesoporous Silica Nanoparticles as Cell Markers , 2005 .
[21] M. Vallet‐Regí,et al. Drug Release and In Vitro Assays of Bioactive Polymer/Glass Mixtures , 2003 .
[22] Jenny Andersson,et al. Influences of Material Characteristics on Ibuprofen Drug Loading and Release Profiles from Ordered Micro- and Mesoporous Silica Matrices , 2004 .
[23] J. B. Higgins,et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates , 1992 .
[24] M. Stébé,et al. Influence of Alkyl Peptidoamines on the Structure of Functionalized Mesoporous Silica , 2004 .
[25] M. Stébé,et al. Functionalization of mesoporous silica by condensation of tetramethoxysilane and alkyl peptidoamine monomers in the presence of a non-ionic fluorinated surfactant , 2005 .
[26] R. Langer,et al. Drug delivery and targeting. , 1998, Nature.
[27] K. Kataoka,et al. Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.
[28] T. Taguchi,et al. Photo-Switched Storage and Release of Guest Molecules in the Pore Void of Coumarin-Modified MCM-41 , 2003 .
[29] J. Devoisselle,et al. Synthesis and characterisation of ibuprofen-anchored MCM-41 silica and silica gel , 2003 .
[30] J. Xue,et al. PLGA/mesoporous silica hybrid structure for controlled drug release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[31] A. G. Oertli,et al. Alkaline Lyotropic Silicate−Surfactant Liquid Crystals , 1997 .
[32] Anna Carlsson,et al. Structural study of mesoporous MCM-48 and carbon networks synthesized in the spaces of MCM-48 by electron crystallography , 2002 .
[33] M. Vallet‐Regí,et al. In vitro release of gentamicin from OHAp/PEMA/PMMA samples. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[34] J. M. Thomas. Uniforme heterogene Katalysatoren – die Rolle der Festkörperchemie bei der Katalysatorentwicklung , 1988 .
[35] M. Vallet‐Regí,et al. Tissue regeneration: A new property of mesoporous materials , 2005 .
[36] Sang Bok Lee,et al. Magnetic nanotubes for magnetic-field-assisted bioseparation, biointeraction, and drug delivery. , 2005, Journal of the American Chemical Society.
[37] Yasuhiro Sakamoto,et al. Direct imaging of the pores and cages of three-dimensional mesoporous materials , 2000, Nature.
[38] J. Choy,et al. Inorganic delivery vector for intravenous injection. , 2004, Biomaterials.
[39] G. Lu,et al. A NOVEL METHOD FOR TAILORING THE PORE-OPENING SIZE OF MCM-41 MATERIALS , 1999 .
[40] T. Coradin,et al. Immobilisation of single molecule magnets in mesoporous silica hosts , 2003 .
[41] S A Goldstein,et al. Skeletal repair by in situ formation of the mineral phase of bone. , 1995, Science.
[42] B. K. Mishra,et al. Chemical modification of silica surface by immobilization of functional groups for extractive concentration of metal ions. , 2004, Talanta.
[43] M. Vallet‐Regí,et al. Revisiting silica based ordered mesoporous materials: medical applications , 2006 .
[44] Yufang Zhu,et al. Hollow mesoporous spheres with cubic pore network as a potential carrier for drug storage and its in vitro release kinetics , 2005 .
[45] P. Dutta,et al. Controlled release of paraquat from surface-modified zeolite Y , 2006 .
[46] Masahiro Fujiwara,et al. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica , 2003, Nature.
[47] V. Constantino,et al. Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides. , 2005, Journal of pharmaceutical sciences.
[48] Avelino Corma,et al. From Microporous to Mesoporous Molecular Sieve Materials and Their Use in Catalysis. , 1997, Chemical reviews.
[49] J. Devoisselle,et al. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[50] M. Vallet‐Regí,et al. Mesoporous MCM-41 as Drug Host System , 2003 .
[51] G. Giammona,et al. Mesoporous silicate as matrix for drug delivery systems of non-steroidal antinflammatory drugs , 2002 .
[52] Brian J. Melde,et al. Hybrid Inorganic–Organic Mesoporous Silicates—Nanoscopic Reactors Coming of Age , 2000 .
[53] M. Vallet‐Regí,et al. Bioactive Carbonate−Hydroxyapatite Coatings Deposited onto Ti6Al4V Substrate , 2004 .
[54] Victor S-Y Lin,et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.
[55] M. Vallet‐Regí,et al. Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin , 2004 .
[56] M. Honkanen,et al. Synthesis of sol–gel silica materials providing a slow release of biphosphonate , 2005 .
[57] J. M. Thomas. Design, Synthese und In‐situ‐Charakterisierung neuer Feststoffkatalysatoren , 1999 .
[58] K. Ariga,et al. Recent advances in functionalization of mesoporous silica. , 2005, Journal of nanoscience and nanotechnology.
[59] John Meurig Thomas. Uniform Heterogeneous Catalysts: The Role of Solid‐State Chemistry in their Development and Design , 1988 .
[60] Hybrid Mesoporous Materials with Functionalized Monolayers , 1998 .
[61] V. S. Lin,et al. Real-Time Imaging of Tunable Adenosine 5-Triphosphate Release from an MCM-41-Type Mesoporous Silica Nanosphere-Based Delivery System , 2005, Applied spectroscopy.
[62] J. S. Beck,et al. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism , 1992, Nature.
[63] Yufang Zhu,et al. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. , 2005, Angewandte Chemie.
[64] M. Vallet‐Regí,et al. Bioactivity in ordered mesoporous materials , 2004 .
[65] C. Serre,et al. A Chromium Terephthalate-Based Solid with Unusually Large Pore Volumes and Surface Area , 2005, Science.
[66] T. Okano,et al. Pulsatile drug delivery systems using hydrogels , 1993 .
[67] Weizhen Zeng,et al. Organic modified mesoporous MCM-41 through solvothermal process as drug delivery system , 2005 .
[68] F. Xiao,et al. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery , 2005 .
[69] María Vallet-Regí,et al. Ceramics for medical applications , 2001 .
[70] Alastair J. Florence,et al. Refinement of Ibuprofen at 100K by Single-Crystal Pulsed Neutron Diffraction , 1997 .
[71] Larry L. Hench,et al. Bonding mechanisms at the interface of ceramic prosthetic materials , 1971 .
[72] M. Vallet‐Regí,et al. Influence of pore size of MCM-41 matrices on drug delivery rate , 2004 .
[73] John Meurig Thomas. The chemistry of crystalline sponges , 1994, Nature.
[74] J. Jansen,et al. A new method to produce macropores in calcium phosphate cements. , 2002, Biomaterials.